KOOL - セスカ・セラピュ―ティクス (Cesca Therapeutics Inc.)

KOOLのニュース

   The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger  2019/09/24 12:12:30 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 23.) Applied Therapeutics Inc (NASDAQ: APLT ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) ( announced a communication from the FDA allowing it to proceed with a reduced sample size in a Phase 3 study of its drug to treat excessive daytime sleepiness) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Celgene Corporation (NASDAQ: CELG ) Cesca Therapeutics Inc (NASDAQ: KOOL ) DURECT Corporation (NASDAQ: DRRX ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) Sanofi SA (NASDAQ: SNY ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 23) Aduro BioTech Inc (NASDAQ: ADRO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Akcea Therapeutics Inc (NASDAQ: AKCA ) (announced departures of CEO, president and COO, and the appointment of board member Damien McDevitt as interim CEO) BioNano Genomics Inc (NASDAQ: BNGO ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) Clovis Oncology Inc (NASDAQ: CLVS ) (announced acquisition of rights to FAP-targeted radiopharmaceuticals from 3B Pharmaceuticals for $12 million) Erytech Pharma SA (NASDAQ: ERYP ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Kalvista Pharmaceuticals Inc (NASDAQ: KALV ) KITOV PHARMA LT/S ADR (NASDAQ: KTOV ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Neon …
   Cesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q1 2019 Results - Earnings Call Transcript  2019/05/14 23:45:04 Seeking Alpha
Cesca Therapeutics Inc. (NASDAQ:KOOL) Q1 2019 Earnings Conference Call May 14, 2019 4:30 PM ET Company Participants Paula Schwartz - Managing Director, Rx Commu
   Cesca Therapeutics EPS in-line, misses on revenue  2019/05/14 20:15:17 Seeking Alpha
Cesca Therapeutics (KOOL): Q1 GAAP EPS of -$0.08 in-line. Revenue of $2.96M (+58.3% Y/Y) misses by $0.14M. Shares +0.75%. Press Release
   Will Cesca Therapeutics (KOOL) Report Negative Q1 Earnings? What You Should Know  2019/05/06 14:30:21 Zacks Investment Research
Cesca Therapeutics (KOOL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Cesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q4 2018 Results - Earnings Call Transcript  2019/03/25 23:30:08 Seeking Alpha
   The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger  2019/09/24 12:12:30 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 23.) Applied Therapeutics Inc (NASDAQ: APLT ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) ( announced a communication from the FDA allowing it to proceed with a reduced sample size in a Phase 3 study of its drug to treat excessive daytime sleepiness) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Celgene Corporation (NASDAQ: CELG ) Cesca Therapeutics Inc (NASDAQ: KOOL ) DURECT Corporation (NASDAQ: DRRX ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) Sanofi SA (NASDAQ: SNY ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 23) Aduro BioTech Inc (NASDAQ: ADRO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Akcea Therapeutics Inc (NASDAQ: AKCA ) (announced departures of CEO, president and COO, and the appointment of board member Damien McDevitt as interim CEO) BioNano Genomics Inc (NASDAQ: BNGO ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) Clovis Oncology Inc (NASDAQ: CLVS ) (announced acquisition of rights to FAP-targeted radiopharmaceuticals from 3B Pharmaceuticals for $12 million) Erytech Pharma SA (NASDAQ: ERYP ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Kalvista Pharmaceuticals Inc (NASDAQ: KALV ) KITOV PHARMA LT/S ADR (NASDAQ: KTOV ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Neon …
   Cesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q1 2019 Results - Earnings Call Transcript  2019/05/14 23:45:04 Seeking Alpha
Cesca Therapeutics Inc. (NASDAQ:KOOL) Q1 2019 Earnings Conference Call May 14, 2019 4:30 PM ET Company Participants Paula Schwartz - Managing Director, Rx Commu
   Cesca Therapeutics EPS in-line, misses on revenue  2019/05/14 20:15:17 Seeking Alpha
Cesca Therapeutics (KOOL): Q1 GAAP EPS of -$0.08 in-line. Revenue of $2.96M (+58.3% Y/Y) misses by $0.14M. Shares +0.75%. Press Release
   Will Cesca Therapeutics (KOOL) Report Negative Q1 Earnings? What You Should Know  2019/05/06 14:30:21 Zacks Investment Research
Cesca Therapeutics (KOOL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Cesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q4 2018 Results - Earnings Call Transcript  2019/03/25 23:30:08 Seeking Alpha
   The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger  2019/09/24 12:12:30 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 23.) Applied Therapeutics Inc (NASDAQ: APLT ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) ( announced a communication from the FDA allowing it to proceed with a reduced sample size in a Phase 3 study of its drug to treat excessive daytime sleepiness) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Celgene Corporation (NASDAQ: CELG ) Cesca Therapeutics Inc (NASDAQ: KOOL ) DURECT Corporation (NASDAQ: DRRX ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) Sanofi SA (NASDAQ: SNY ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 23) Aduro BioTech Inc (NASDAQ: ADRO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Akcea Therapeutics Inc (NASDAQ: AKCA ) (announced departures of CEO, president and COO, and the appointment of board member Damien McDevitt as interim CEO) BioNano Genomics Inc (NASDAQ: BNGO ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) Clovis Oncology Inc (NASDAQ: CLVS ) (announced acquisition of rights to FAP-targeted radiopharmaceuticals from 3B Pharmaceuticals for $12 million) Erytech Pharma SA (NASDAQ: ERYP ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Kalvista Pharmaceuticals Inc (NASDAQ: KALV ) KITOV PHARMA LT/S ADR (NASDAQ: KTOV ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Neon …
   Cesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q1 2019 Results - Earnings Call Transcript  2019/05/14 23:45:04 Seeking Alpha
Cesca Therapeutics Inc. (NASDAQ:KOOL) Q1 2019 Earnings Conference Call May 14, 2019 4:30 PM ET Company Participants Paula Schwartz - Managing Director, Rx Commu
   Cesca Therapeutics EPS in-line, misses on revenue  2019/05/14 20:15:17 Seeking Alpha
Cesca Therapeutics (KOOL): Q1 GAAP EPS of -$0.08 in-line. Revenue of $2.96M (+58.3% Y/Y) misses by $0.14M. Shares +0.75%. Press Release
   Will Cesca Therapeutics (KOOL) Report Negative Q1 Earnings? What You Should Know  2019/05/06 14:30:21 Zacks Investment Research
Cesca Therapeutics (KOOL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Cesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q4 2018 Results - Earnings Call Transcript  2019/03/25 23:30:08 Seeking Alpha

calendar